Gene Disruption of Plasmodium falciparum p52 Results in Attenuation of Malaria Liver Stage Development
Author Information
Author(s): Ben C. L. van Schaijk, Chris J. Janse, Geert-Jan van Gemert, Melissa R. van Dijk, Audrey Gego, Jean-Francois Franetich, Marga van de Vegte-Bolmer, Samir Yalaoui, Olivier Silvie, Stephen L. Hoffman, Andrew P. Waters, Dominique Mazier, Robert W. Sauerwein, Shahid M. Khan
Primary Institution: Radboud University Nijmegen Medical Centre
Hypothesis
Disrupting the p52 gene in Plasmodium falciparum will lead to attenuation of liver stage development in human hepatocytes.
Conclusion
Disrupting the p52 gene in P. falciparum results in parasites that are arrested early during liver stage development, similar to findings in rodent models.
Supporting Evidence
- Disruption of the p52 gene leads to early arrest of liver stage development in P. falciparum.
- The Δp52 mutants show comparable gliding motility and cell traversal to wild-type sporozoites.
- Immunization with genetically attenuated sporozoites may confer protective immunity against malaria.
Takeaway
Scientists changed a gene in malaria parasites to see if it would stop them from growing in the liver, and it worked! This could help make a new type of vaccine.
Methodology
The study involved gene disruption of p52 in P. falciparum and analysis of sporozoite invasion and development in primary human hepatocytes.
Limitations
The study may have low levels of wild-type contamination due to potential reversion events in mutant parasites.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website